Updated pharmacological management of rheumatoid arthritis for women before, during, and after pregnancy, reflecting recent guidelines

@article{Murray2018UpdatedPM,
  title={Updated pharmacological management of rheumatoid arthritis for women before, during, and after pregnancy, reflecting recent guidelines},
  author={Kieran E Murray and Louise Moore and Celine O'Brien and Anne B. Clohessy and Caroline Brophy and Patricia Brigid Minnock and Oliver M Fitzgerald and Eamonn S. Molloy and A Mongey and Shane P Higgins and Mary Frances Higgins and Fionnuala M Mc Auliffe and Douglas J Veale},
  journal={Irish Journal of Medical Science (1971 -)},
  year={2018},
  volume={188},
  pages={169-172}
}
BackgroundRheumatoid arthritis (RA) is a chronic immune-mediated inflammatory disease which can cause significant disability, morbidity, mortality, and impaired fertility. It commonly affects women of childbearing age. Managing rheumatoid arthritis (RA) in the perinatal period poses challenges. There is concern about the teratogenic effects of many traditional disease-modifying anti-rheumatic drugs (DMARDs) and an ever-growing list of new therapeutic options with limited data in pregnancy and… CONTINUE READING
BETA
3
Twitter Mentions

Similar Papers

Loading similar papers…